News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
266,317 Results
Type
Article (13822)
Company Profile (101)
Press Release (252394)
Multimedia
Podcasts (47)
Webinars (10)
Section
Business (88131)
Career Advice (465)
Deals (15352)
Drug Delivery (67)
Drug Development (36617)
Employer Resources (49)
FDA (6320)
Job Trends (6202)
News (150364)
Policy (14055)
Tag
Academia (441)
Accelerated approval (2)
Adcomms (6)
Allergies (36)
Alliances (23246)
ALS (38)
Alzheimer's disease (394)
Antibody-drug conjugate (ADC) (43)
Approvals (6359)
Artificial intelligence (113)
Autoimmune disease (9)
Automation (4)
Bankruptcy (149)
Best Places to Work (4370)
BIOSECURE Act (9)
Biosimilars (57)
Biotechnology (40)
Bladder cancer (22)
Brain cancer (16)
Breast cancer (83)
Cancer (649)
Cardiovascular disease (73)
Career advice (409)
Career pathing (12)
CAR-T (23)
Cell therapy (90)
Cervical cancer (4)
Clinical research (30969)
Collaboration (356)
Compensation (165)
Complete response letters (17)
COVID-19 (760)
CRISPR (22)
C-suite (131)
Cystic fibrosis (38)
Data (677)
Denatured (15)
Depression (10)
Diabetes (83)
Diagnostics (1327)
Diversity (2)
Diversity, equity & inclusion (13)
Drug discovery (61)
Drug pricing (67)
Drug shortages (12)
Duchenne muscular dystrophy (37)
Earnings (32309)
Editorial (12)
Employer branding (4)
Employer resources (43)
Events (37624)
Executive appointments (404)
FDA (6770)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (219)
Gene editing (40)
Generative AI (9)
Gene therapy (102)
GLP-1 (350)
Government (1302)
Grass and pollen (3)
Guidances (28)
Healthcare (3587)
Huntington's disease (4)
IgA nephropathy (12)
Immunology and inflammation (36)
Indications (14)
Infectious disease (795)
Inflammatory bowel disease (57)
Inflation Reduction Act (6)
Influenza (14)
Intellectual property (48)
Interviews (59)
IPO (5887)
IRA (29)
Job creations (2051)
Job search strategy (373)
Kidney cancer (6)
Labor market (12)
Layoffs (181)
Leadership (4)
Legal (3436)
Liver cancer (19)
Lung cancer (88)
Lymphoma (57)
Machine learning (2)
Management (16)
Manufacturing (165)
MASH (34)
Medical device (1281)
Medtech (1283)
Mergers & acquisitions (9678)
Metabolic disorders (267)
Multiple sclerosis (21)
NASH (14)
Neurodegenerative disease (25)
Neuropsychiatric disorders (8)
Neuroscience (585)
NextGen: Class of 2025 (1586)
Non-profit (595)
Now hiring (8)
Obesity (152)
Opinion (119)
Ovarian cancer (22)
Pain (56)
Pancreatic cancer (16)
Parkinson's disease (47)
Partnered (7)
Patents (125)
Patient recruitment (31)
Peanut (10)
People (29008)
Pharmaceutical (64)
Pharmacy benefit managers (11)
Phase I (8058)
Phase II (13096)
Phase III (11765)
Pipeline (482)
Policy (73)
Postmarket research (1401)
Preclinical (3235)
Press Release (25)
Prostate cancer (48)
Psychedelics (8)
Radiopharmaceuticals (120)
Rare diseases (171)
Real estate (2637)
Recruiting (17)
Regulatory (10155)
Reports (14)
Research institute (566)
Resumes & cover letters (55)
Rett syndrome (1)
RNA editing (2)
RSV (8)
Schizophrenia (37)
Series A (38)
Series B (15)
Service/supplier (3)
Sickle cell disease (32)
Special edition (6)
Spinal muscular atrophy (77)
Sponsored (6)
Startups (1629)
State (2)
Stomach cancer (3)
Supply chain (32)
Tariffs (33)
The Weekly (30)
Vaccines (158)
Venture capitalists (14)
Weight loss (100)
Women's health (8)
Worklife (4)
Date
Today (60)
Last 7 days (280)
Last 30 days (935)
Last 365 days (11743)
2025 (4035)
2024 (12520)
2023 (14263)
2022 (19567)
2021 (20074)
2020 (19039)
2019 (14886)
2018 (11714)
2017 (13890)
2016 (13134)
2015 (15475)
2014 (12420)
2013 (10596)
2012 (11402)
2011 (11928)
2010 (10895)
Location
Africa (313)
Alabama (13)
Alaska (1)
Arizona (57)
Arkansas (3)
Asia (20157)
Australia (2616)
California (1802)
Canada (959)
China (251)
Colorado (71)
Connecticut (71)
Delaware (62)
Europe (39540)
Florida (342)
Georgia (39)
Idaho (9)
Illinois (205)
India (16)
Indiana (138)
Iowa (1)
Japan (98)
Kansas (58)
Kentucky (13)
Louisiana (1)
Maine (2)
Maryland (266)
Massachusetts (1553)
Michigan (30)
Minnesota (97)
Missouri (23)
Montana (8)
Nebraska (6)
Nevada (9)
New Hampshire (6)
New Jersey (795)
New Mexico (7)
New York (540)
North Carolina (407)
North Dakota (2)
Northern California (742)
Ohio (51)
Oklahoma (4)
Oregon (16)
Pennsylvania (464)
Puerto Rico (8)
Rhode Island (10)
South America (502)
South Carolina (2)
Southern California (757)
Tennessee (35)
Texas (239)
United States (7536)
Utah (36)
Virginia (79)
Washington D.C. (32)
Washington State (124)
Wisconsin (18)
266,317 Results for "tigris pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Spectral Medical Completes Tigris Trial Enrollment
April 16, 2025
·
5 min read
Press Releases
Spectral Medical Provides February Tigris Trial Update
March 3, 2025
·
3 min read
Press Releases
Spectral Medical Provides January Tigris Trial Update
February 3, 2025
·
3 min read
Press Releases
Spectral Medical Provides December Tigris Trial Update
January 6, 2025
·
3 min read
Press Releases
Spectral Medical Provides November Tigris Trial Update
December 2, 2024
·
4 min read
Press Releases
Spectral Medical Provides October Tigris Trial Update
November 5, 2024
·
3 min read
Spectral Medical Provides April 2024 Tigris Trial Update
Spectral Medical Inc., a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, provided an update on the Company’s Tigris trial, a Phase 3 follow-on study evaluating the use of Polymyxin B Hemoperfusion in a randomized controlled trial of adults treated for endotoxemia and septic shock.
May 6, 2024
·
3 min read
Drug Development
Spectral Medical Provides February Tigris Trial Update
Spectral Medical Inc. today provided an update on the Company’s Tigris trial, a Phase 3 follow-on study evaluating the use of Polymyxin B Hemoperfusion (“PMX”) in a randomized controlled trial of adults treated for endotoxemia and septic shock.
February 28, 2024
·
3 min read
Drug Development
Spectral Medical Provides Tigris Trial Update - April 10, 2024
Spectral Medical Inc., a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, provided an update on the Company’s Tigris trial, a Phase 3 follow-on study evaluating the use of Polymyxin B Hemoperfusion in a randomized controlled trial of adults treated for endotoxemia and septic shock.
April 10, 2024
·
3 min read
Press Releases
Spectral Medical Provides August Tigris Trial Update
September 3, 2024
·
4 min read
1 of 26,632
Next
